The effect of curcumin on heart functio
Phase 1
- Conditions
- dialysis.Chronic kidney disease, stage 5
- Registration Number
- IRCT2015011617413N10
- Lead Sponsor
- Atherosclerosis Research Center of Baqiyatallah University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
inclusion criteria: all patients with chronic renal failure undergoing dialysis in dialysis center of Baqiyatallah Hospital
exclusion criteria: history of cardiac diseases (due to history taking and non invasive tests); pregnancy and breastfeeding; informed refusal of consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eft Ventricle Ejection Fraction. Timepoint: Baseline, six weeks after the beginning of the study. Method of measurement: Echocardiography.;Left Ventricle Size. Timepoint: Baseline, six weeks after the beginning of the study. Method of measurement: Echocardiography by measuring volume and diametre of left ventricle.
- Secondary Outcome Measures
Name Time Method Hb. Timepoint: before intervention. Method of measurement: blood sampling.;PTH. Timepoint: before intervention. Method of measurement: blood sampling.